IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner

Journal of Cellular Biochemistry

Volumn 113, Issue 9, 2012, Pages 2895-2902

  Deselm, Carl J ^a   Takahata, Yoshifumi ^a   Warren, Julia ^a   Chappel, Jean C ^a   Khan, Taimur ^a   Li, Xiaoxia ^b   Liu, Caini ^b   Choi, Yongwon ^c   Kim, Youngmi Faith ^c   Zou, Wei ^a   Teitelbaum, Steven L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

cytokines; Interleukin 17; osteoclast Osteoblast biology; osteoporosis

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 17 RECEPTOR; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN; PROTEIN ACT 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESTROGEN DEFICIENCY; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; FEMALE; INTERLEUKIN-17; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; OVARIECTOMY; RANK LIGAND; RECEPTORS, INTERLEUKIN-17; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; X-RAY MICROTOMOGRAPHY;

MUS;

EID: 84863710982     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24165     Document Type: Article

References (43)

1. Adamopoulos IE, Chao CC, Geissler R, Laface D, Blumenschein W, Iwakura Y, McClanahan T, Bowman EP,. 2010. Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors. Arthritis Res Ther 12: R29.
2. Ammann P, Rizzoli R, Bonjour JP, Bourrin S, Meyer JM, Vassalli P, Garcia I,. 1997. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest 99: 1699-1703.
3. Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Pacifici R,. 2000. Estrogen deficiency induces bone loss by enhancing T cell production of TNFα. J Clin Invest 106: 1229-1237.
4. D'Amelio P, Grimaldi A, Di Bella S, Brianza SZ, Cristofaro MA, Tamone C, Giribaldi G, Ulliers D, Pescarmona GP, Isaia G,. 2008. Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: A key mechanism in osteoporosis. Bone 43: 92-100.
5. Darnay BG, Ni J, Moore PA, Aggarwal BB,. 1999. Activation of NF-κB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-κB-inducing kinase. J Biol Chem 274: 7724-7731.
6. Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen ZJ,. 2000. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103: 351-361.
7. DeSelm CJ, Miller BC, Zou W, Beatty WL, van Meel E, Takahata Y, Klumperman J, Tooze SA, Teitelbaum SL, Virgin HW,. 2011. Autophagy proteins regulate the secretory component of osteoclastic bone resorption. Dev Cell 21: 966-974.
8. Formica C, Loro ML, Gilsanz V, Seeman E,. 1995. Inhomogeneity in body fat distribution may result in inaccuracy in the measurement of vertebral bone mass. J Bone Miner Res 10: 1504-1511.
9. Gaffen SL,. 2009. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9: 556-567.
10. Goswami J, Hernandez-Santos N, Zuniga LA, Gaffen SL,. 2009. A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. Eur J Immunol 39: 2831-2839.
11. Hangartner TN, Johnston CC,. 1990. Influence of fat on bone measurements with dual-energy absorptiometry. Bone Miner 9: 71-81.
12. Huang H, Kim HJ, Chang EJ, Lee ZH, Hwang SJ, Kim HM, Lee Y, Kim HH,. 2009. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: Implications for bone remodeling. Cell Death Differ 16: 1332-1343.
13. Kimble RB, Bain S, Pacifici R,. 1997. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 12: 935-941.
14. Kitaura H, Sands MS, Aya K, Zhou P, Hirayama T, Uthgenannt B, Wei S, Takeshita S, Novack DV, Silva MJ, Abu-Amer Y, Ross FP, Teitelbaum SL,. 2004. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-α-induced osteoclastogenesis in vivo. J Immunol 173: 4838-4846.
15. Koenders MI, Lubberts E, van de Loo FA, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, Kolls JK, Di Padova FE, Joosten LA, van den Berg WB,. 2006. Interleukin-17 acts independently of TNF-alpha under arthritic conditions. J Immunol 176: 6262-6269.
16. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL,. 2000. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106: 1481-1488.
17. Lee SK, Kadono Y, Okada F, Jacquin C, Koczon-Jaremko B, Gronowicz G, Adams DJ, Aguila HL, Choi Y, Lorenzo JA,. 2006. T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. J Bone Miner Res 21: 1704-1712.
18. Linden A,. 2007. A role for the cytoplasmic adaptor protein Act1 in mediating IL-17 signaling. Sci STKE 2007: re4.
19. Liu HB, Loo KK, Palaszynski K, Ashouri J, Lubahn DB, Voskuhl RR,. 2003. Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. J Immunol 171: 6936-6940.
20. Liu C, Qian W, Qian Y, Giltiay NV, Lu Y, Swaidani S, Misra S, Deng L, Chen ZJ, Li X,. 2009. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci Signal 2: ra63.
21. Liu C, Swaidani S, Qian W, Kang Z, Sun P, Han Y, Wang C, Gulen MF, Yin W, Zhang C, Fox PL, Aronica M, Hamilton TA, Misra S, Deng J, Li X,. 2011. A CC' loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation. Sci Signal 4: ra72.
22. Lubberts E, Joosten LA, Oppers B, van den Bersselaar L, Coenen-de Roo CJ, Kolls JK, Schwarzenberger P, van de Loo FA, van den Berg WB,. 2001. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 167: 1004-1013.
23. Maitra A, Shen F, Hanel W, Mossman K, Tocker J, Swart D, Gaffen SL,. 2007. Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc Natl Acad Sci USA 104: 7506-7511.
24. Miossec P,. 2003. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum 48: 594-601.
25. Nakae S, Nambu A, Sudo K, Iwakura Y,. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171: 6173-6177.
26. Novatchkova M, Leibbrandt A, Werzowa J, Neubuser A, Eisenhaber F,. 2003. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem Sci 28: 226-229.
27. Onishi RM, Park SJ, Hanel W, Ho AW, Maitra A, Gaffen SL,. 2010. SEF/IL-17R (SEFIR) is not enough: An extended SEFIR domain is required for il-17RA-mediated signal transduction. J Biol Chem 285: 32751-32759.
28. Pacifici R,. 2010. The immune system and bone. Arch Biochem Biophys 503: 41-53.
29. Pernis AB,. 2007. Estrogen and CD4+ T cells. Curr Opin Rheumatol 19: 414-420.
30. Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D, Xiao J, Lu Y, Giltiay N, Liu J, Kordula T, Zhang QW, Vallance B, Swaidani S, Aronica M, Tuohy VK, Hamilton T, Li X,. 2007. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 8: 247-256.
31. Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R,. 2001. Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 98: 13960-13965.
32. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H,. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203: 2673-2682.
33. Shin JH, Shin DW, Noh M,. 2009. Interleukin-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates pro-inflammatory responses in adipocytes. Biochem Pharmacol 77: 1835-1844.
34. Straub RH,. 2007. The complex role of estrogens in inflammation. Endocr Rev 28: 521-574.
35. Sumarac-Dumanovic M, Stevanovic D, Ljubic A, Jorga J, Simic M, Stamenkovic-Pejkovic D, Starcevic V, Trajkovic V, Micic D,. 2009. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes (Lond) 33: 151-156.
36. Swaidani S, Bulek K, Kang Z, Liu C, Lu Y, Yin W, Aronica M, Li X,. 2009. The critical role of epithelial-derived Act1 in IL-17- and IL-25-mediated pulmonary inflammation. J Immunol 182: 1631-1640.
37. Tajima M, Wakita D, Noguchi D, Chamoto K, Yue Z, Fugo K, Ishigame H, Iwakura Y, Kitamura H, Nishimura T,. 2008. IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells. J Exp Med 205: 1019-1027.
38. Tothill P, Hannan WJ, Cowen S, Freeman CP,. 1997. Anomalies in the measurement of changes in total-body bone mineral by dual-energy X-ray absorptiometry during weight change. J Bone Miner Res 12: 1908-1921.
39. Tothill P, Laskey MA, Orphanidou CI, van Wijk M,. 1999. Anomalies in dual energy X-ray absorptiometry measurements of total-body bone mineral during weight change using Lunar, Hologic and Norland instruments. Br J Radiol 72: 661-669.
40. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ,. 2001. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412: 346-351.
41. Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL,. 2005. IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 115: 282-290.
42. Wren TA, Kim PS, Janicka A, Sanchez M, Gilsanz V,. 2007. Timing of peak bone mass: Discrepancies between CT and DXA. J Clin Endocrinol Metab 92: 938-941.
43. Yasui T, Uemura H, Yamada M, Matsuzaki T, Tsuchiya N, Noguchi M, Yuzurihara M, Kase Y, Irahara M,. 2008. Associations of interleukin-6 with interleukin-1beta, interleukin-8 and macrophage inflammatory protein-1beta in midlife women. Cytokine 41: 302-306.